Real-world data (RWD) can come from a variety of sources, including claims, electronic health records, biobanks, genomics tests, and imaging modalities. Increasingly, it is coming from digital data through electronic health and mobile health modalities. Recent events have pushed innovation in the use of RWD to maximize the value of real-world evidence in an era of big data, data science, and artificial intelligence.
clinical trials
Dooti Roy
Dooti Roy spent her weekends as a child in Kolkata working on puzzles and combinatorics and reading storybooks. She was introduced to statistics when she was 16 and enjoyed it so much that she earned a graduate fellowship to pursue her PhD in the US. Today, she works as a methodologist at Boehringer Ingelheim, Inc., where her days are spent learning, researching, and implementing statistical methods to make clinical trials more efficient. Even though her job is challenging, she learns constantly and solves meaningful and complex problems to help patients in need. Recently, she has been mentoring younger statisticians and actively volunteers her time on several ASA committees, including the Antiracism Task Force.
Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials
The editorial team invited authors from government, industry, and academia to write articles about their perspectives on the impact of COVID-19 on clinical trials, particularly the statistical issues involved in designing new COVID-19 trials.
To Get a PhD or Not to Get a PhD? Part 3
The ASA Committee on Applied Statisticians is giving you the experiences of four statisticians who took different paths after their master’s degrees. This month, Allison Florance explains why she found a master’s degree to be right for her.
People News for November 2020
Marie Diener-West and Erin Tanenbaum were honored recently.
Statistical Consulting Section Responds to COVID-19
Applied and practicing statisticians in the ASA Statistical Consulting Section are engaged and playing key roles in COVID-19 research. Here, we highlight members of the section who are responding to COVID-19.
Dionne Price
Dionne Price always enjoyed applied mathematics in school, but it was the chance to intern for the National Institute for Neurological Disorders and Stroke that sparked her love of biostatistics. Now at the FDA, she provides leadership to statisticians involved in the development and application of methodology used in the regulation of anti-infective, anti-viral, ophthalmology, rare diseases, urology, and reproductive drug products. She also writes poetry, including “The Journey” here.
Ellenberg Appointed Interim Chair
Susan S. Ellenberg was been appointed interim chair of the department of biostatistics, epidemiology, and informatics at the University of Pennsylvania Perelman School of Medicine.
Center for Clinical Epidemiology and Biostatistics to Hold Conference on Electronic Health Records
The Center for Clinical Epidemiology and Biostatistics 12th Annual UPENN Conference on Statistical Issues in Clinical Trials will be held April 17.
Biometrics Section News for June
Registration is open for “Biomedical Statistical Modeling: A Conference in Honor of Jeremy Taylor’s 60th Birthday,” to be held June 9–10 at the University of Michigan in Ann Arbor.